Hochhaus A - Search Results

1

Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study.

Talpaz M, Silver RT, Druker BJ, Goldman JM, Gambacorti-Passerini C, Guilhot F, Schiffer CA, Fischer T, Deininger MW, Lennard AL, Hochhaus A, Ottmann OG, Gratwohl A, Baccarani M, Stone R, Tura S, Mahon FX, Fernandes-Reese S, Gathmann I, Capdeville R, Kantarjian HM, Sawyers CL. Talpaz M, et al. Among authors: hochhaus a. Blood. 2002 Mar 15;99(6):1928-37. doi: 10.1182/blood.v99.6.1928. Blood. 2002. PMID: 11877262 Free article. Clinical Trial.

2

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Br J Haematol. 1995 Sep;91(1):126-31. doi: 10.1111/j.1365-2141.1995.tb05257.x. Br J Haematol. 1995. PMID: 7577619

3

Randomized comparison of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous leukemia. The German CML Study Group.

Hehlmann R, Heimpel H, Hasford J, Kolb HJ, Pralle H, Hossfeld DK, Queisser W, Löffler H, Hochhaus A, Heinze B, et al. Hehlmann R, et al. Among authors: hochhaus a. Blood. 1994 Dec 15;84(12):4064-77. Blood. 1994. PMID: 7994025 Free article. Clinical Trial.

4

Interferon in chronic myeloid leukemia. A workshop report.

Griesshammer M, Hehlmann R, Hochhaus A, Talpaz M, Tura S, Stryckmans P, Allan NC, Tanzer J, Kolb HJ, Heimpel H. Griesshammer M, et al. Among authors: hochhaus a. Ann Hematol. 1993 Aug;67(2):101-6. doi: 10.1007/BF01788134. Ann Hematol. 1993. PMID: 8347729 Review.

5

Quantification of residual disease in chronic myelogenous leukemia patients on interferon-alpha therapy by competitive polymerase chain reaction.

Hochhaus A, Lin F, Reiter A, Skladny H, Mason PJ, van Rhee F, Shepherd PC, Allan NC, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Blood. 1996 Feb 15;87(4):1549-55. Blood. 1996. PMID: 8608246 Free article.

6

Lack of correlation between ABL-BCR expression and response to interferon-alpha in chronic myeloid leukaemia.

Melo JV, Hochhaus A, Yan XH, Goldman JM. Melo JV, et al. Among authors: hochhaus a. Br J Haematol. 1996 Mar;92(3):684-6. doi: 10.1046/j.1365-2141.1996.00350.x. Br J Haematol. 1996. PMID: 8616036

7

p190 BCR-ABL mRNA is expressed at low levels in p210-positive chronic myeloid and acute lymphoblastic leukemias.

van Rhee F, Hochhaus A, Lin F, Melo JV, Goldman JM, Cross NC. van Rhee F, et al. Among authors: hochhaus a. Blood. 1996 Jun 15;87(12):5213-7. Blood. 1996. PMID: 8652835 Free article.

8

Expression of the LH2 gene in chronic myeloid leukaemia cells.

Al-Jehani F, Hochhaus A, Spencer A, Goldman JM, Melo JV. Al-Jehani F, et al. Among authors: hochhaus a. Leukemia. 1996 Jul;10(7):1122-6. Leukemia. 1996. PMID: 8683990

9

Quantitative molecular methods to monitor the response of CML patients to interferon-alpha.

Hochhaus A, Lin F, Reiter A, Skladny H, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Bone Marrow Transplant. 1996 May;17 Suppl 3:S41-4. Bone Marrow Transplant. 1996. PMID: 8769700

10

A novel BCR-ABL fusion gene (e6a2) in a patient with Philadelphia chromosome-negative chronic myelogenous leukemia.

Hochhaus A, Reiter A, Skladny H, Melo JV, Sick C, Berger U, Guo JQ, Arlinghaus RB, Hehlmann R, Goldman JM, Cross NC. Hochhaus A, et al. Blood. 1996 Sep 15;88(6):2236-40. Blood. 1996. PMID: 8822944 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

682 results

Search Page